Comparison of Transition rates with the LG (0, 1)* spiral-phase mode field distribution in the frame of three ionization theories
Bulletin of Natural Sciences Research · 2021
DOI: 10.5937/bnsr11-28954 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Natural Sciences Research, 2021. Verfasst von Tatjana Miladinović und 1 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Ministry of Education, Science and Technological Development of the Republic of Serbia.
Abstract (Originalsprache)
We discussed the tunneling ionization of an Argon atom placed in a strong low-frequency field of Ti: Sapphire laser. The transition rate of the electron obtained with radial polarization LG (0, 1)* spiral-phase mode field distribution included are compared to the basic transition rate. All analyses are given in the frame of the three different ionization theories-Keldysh, PPT, and ADK. We demonstrated that the tunneling transition rate is sensitive to laser polarization and a set field distribution. As well as changes in the azimuthal angle as a parameter on which the given distribution depends.
Förderung
- Ministry of Education, Science and Technological Development of the Republic of Serbia
Zitieren
APA
Miladinović, T., & Danilović, N. (2021). Comparison of Transition rates with the LG (0, 1)* spiral-phase mode field distribution in the frame of three ionization theories. Bulletin of Natural Sciences Research. https://doi.org/10.5937/bnsr11-28954
Vancouver
Miladinović T, Danilović N. Comparison of Transition rates with the LG (0, 1)* spiral-phase mode field distribution in the frame of three ionization theories. Bulletin of Natural Sciences Research. 2021. doi:10.5937/bnsr11-28954
BibTeX
@article{Miladinovi2021,
author = {Miladinović, Tatjana and Danilović, Nebojša},
title = {Comparison of Transition rates with the LG (0, 1)* spiral-phase mode field distribution in the frame of three ionization theories},
journal = {Bulletin of Natural Sciences Research},
year = {2021},
doi = {10.5937/bnsr11-28954}
}
EUVIMED